Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1358-1367

  Kulkarni, Onkar P ^a   Ryu, Mi ^a   Kantner, Claudia ^a   Sárdy, Miklós ^a   Naylor, Dean ^b   Lambert, Daniel ^b   Brown, Richard ^b   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CBio Ltd   (Australia)

Author keywords

chaperonin 10; cutaneous lupus erythematosus; immunomodulation; inflammation; lupus nephritis

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL MARKER; CHAPERONIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; RECOMBINANT CHAPERONIN 10; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENDRITIC CELL; DISEASE ACTIVITY; DRUG EFFICACY; DRUG PURITY; FEMALE; IMMUNOMODULATION; LUNG INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN LUPUS ERYTHEMATOSUS; SURVIVAL TIME; T LYMPHOCYTE; TREATMENT RESPONSE;

ANIMALS; AUTOANTIBODIES; BLOTTING, WESTERN; CHAPERONIN 10; FEMALE; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS NEPHRITIS; MICE; MICE, INBRED MRL LPR; PROTEIN CONFORMATION; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 84859350085     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr544     Document Type: Article

References (34)

1. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-939 (Pubitemid 351397092)
2. Karpouzas GA, Kitridou RC. The mother in systemic lupus erythematosus. In. Dubois' Lupus Erythematosus. 7th edn. Philadelphia, PA: Lippincott Williams & Wilkins, Philadelphia, 2007, pp. 992-1038
3. Friedman EA, Rutherford JW. Pregnancy and lupus erythematosus. Obstet Gynecol 1956; 8: 601-610
4. Kokeny G, Godo M, Nagy E et al. Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. Lupus 2007; 16: 465-477 (Pubitemid 47242519)
5. Noonan FP, Halliday WJ, Morton H et al. Early pregnancy factor is immunosuppressive. Nature 1979; 278: 649-651 (Pubitemid 9155488)
6. Athanasas-Platsis S, Corcoran CM, Kaye PL et al. Early pregnancy factor is required at two important stages of embryonic development in the mouse. Am J Reprod Immunol 2000; 43: 223-233 (Pubitemid 30229678)
7. Morton H. Early pregnancy factor: an extracellular chaperonin 10 homologue. Immunol Cell Biol 1998; 76: 483-496 (Pubitemid 29003051)
8. Cavanagh AC, Morton H. The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10. Eur J Biochem 1994; 222: 551-560 (Pubitemid 24204927)
9. Corrao S, Campanella C, Anzalone R et al. Human Hsp10 and early pregnancy factor (EPF) and their relationship and involvement in cancer and immunity: current knowledge and perspectives. Life Sci 2010; 86: 145-152
10. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289 (Pubitemid 351432799)
11. Asea A. Heat shock proteins and toll-like receptors. Handb Exp Pharmacol 2008: (183):111-127
12. Johnson BJ, Le TT, Dobbin CA et al. Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J Biol Chem 2005; 280: 4037-4047 (Pubitemid 40288567)
13. Morton H, McKay DA, Murphy RM et al. Production of a recombinant form of early pregnancy factor that can prolong allogeneic skin graft survival time in rats. Immunol Cell Biol 2000; 78: 603-607
14. Ragno S, Winrow VR, Mascagni P et al. A synthetic 10-kD heat shock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis. Clin Exp Immunol 1996; 103: 384-390 (Pubitemid 26092002)
15. Agnello D, Scanziani E, Di GM et al. Preventive administration of Mycobacterium tuberculosis 10-kDa heat shock protein (hsp10) suppresses adjuvant arthritis in Lewis rats. Int Immunopharmacol 2002; 2: 463-474 (Pubitemid 34169742)
16. Zhang B, Harness J, Somodevilla-Torres MJ et al. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151. J Neurol Sci 2000; 182: 5-15
17. Vanags D, Williams B., Johnson B et al. Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a doubleblind randomised trial. Lancet 2006; 368: 855-863 (Pubitemid 44292809)
18. Williams B, Vanags D, Hall S et al. Efficacy and safety of chaperonin 10 in patients with moderate to severe plaque psoriasis: evidence of utility beyond a single indication. Arch Dermatol 2008; 144: 683-685 (Pubitemid 351724437)
19. Broadley SA, Vanags D, Williams B et al. Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis. Mult Scler 2009; 15: 329-336
20. Hartman DJ, Hoogenraad NJ, Condron R et al. Identification of a mammalian 10-kDa heat shock protein, a mitochondrial chaperonin 10 homologue essential for assisted folding of trimeric ornithine transcarbamoylase in vitro. Proc Natl Acad Sci USA 1992; 89: 3394-3398
21. Ryan MT, Naylor DJ, Hoogenraad NJ et al. Affinity purification, overexpression, and characterization of chaperonin 10 homologues synthesized with and without N-terminal acetylation. J Biol Chem 1995; 270: 22037-22043
22. Somodevilla-Torres MJ, Morton H, Zhang B et al. Purification and characterisation of functional early pregnancy factor expressed in Sf9 insect cells and in Escherichia coli. Protein Expr Purif 2003; 32: 276-287 (Pubitemid 38039020)
23. Brinker A, Pfeifer G, Kerner MJ et al. Dual function of protein confinement in chaperonin-assisted protein folding. Cell 2001; 107: 223-233 (Pubitemid 33035948)
24. Kulkarni O, Pawar RD, Purschke W et al. Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice. J Am Soc Nephrol 2007; 18: 2350-2358 (Pubitemid 47203851)
25. Patole PS, Pawar RD, Lichtnekert J et al. Coactivation of Toll-like receptor-3 and-7 in immune complex glomerulonephritis. J Autoimmun 2007; 29: 52-59 (Pubitemid 47016916)
26. Chan OT, Paliwal V, McNiff JM et al. Deficiency in beta(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL-Fas(lpr) nice: an example of disease regulation at the organ level. J Immunol 2001; 167: 2985-2990 (Pubitemid 32768936)
27. Kulkarni OP, Sayyed SG, Kantner C et al. 4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice. Am J Pathol 2010; 176: 2840-2847
28. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689-695 (Pubitemid 14079965)
29. Kulkarni O, Eulberg D, Selve N et al. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice. J Pharmacol Exp Ther 2009; 328: 371-377
30. Moore KJ, Wada T, Barbee SD et al. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice. Kidney Int 1998; 53: 1631-1641 (Pubitemid 28243746)
31. Fujii T, Okada M, Mimori T et al. The transmembrane form of TNFalpha drives autoantibody production in the absence of CD154: studies using MRL/Mp-Fas(lpr) mice. Clin Exp Immunol 2002; 130: 224-232 (Pubitemid 35286208)
32. Sunderrajan EV, McKenzie WN, Lieske TR et al. Pulmonary inflammation in autoimmune MRL/Mp-lpr/lpr mice. Histopathology and bronchoalveolar lavage evaluation. Am J Pathol 1986; 124: 353-362 (Pubitemid 16016653)
33. Lloyd CM, Gonzalo JA, Salant DJ et al. Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus. J Clin Invest 1997; 100: 963-971 (Pubitemid 27386280)
34. Kim N, Ussin L, Cheng X et al. TNFalpha inhibition in MRL/lpr mice ameliorates pulmonary but not renal disease. J Autoimmun 2002; 19: (Pubitemid 36262936)